Etoricoxib 60mg + Serratiopeptidase 10mg Tablet PCD Company in Haryana

Etoricoxib Serratiopeptidase Tablet Franchise Supplier in Gujarat

Etoricoxib 60mg Serratiopeptidase 10mg Tablet Manufacturer in Himachal Pradesh

Best PCD Pharma for Etoricoxib Serratiopeptidase Tablets in Punjab

Etoricoxib + Serratiopeptidase Tablet Third Party Manufacturer in Uttarakhand
Etoricoxib 60mg Serratiopeptidase 10mg Tablets Exporter from India

Home/Products /xurocitam-60-injection-piracetam-200mg-injection

About the Product

Description


Xurocitam 60 Injection contains Piracetam (200 mg), a nootropic agent that enhances brain metabolism and improves neuronal function. It works by increasing blood flow and oxygen consumption in the brain without affecting blood pressure. This helps improve cognitive abilities, memory, learning capacity, and overall mental performance. Piracetam is also known to have neuroprotective effects, helping in conditions involving brain injury or impaired cerebral circulation. It is commonly used as part of therapy for cognitive decline, post-stroke recovery, dementia, vertigo, and certain movement disorders.

May cause nervousness, irritability, sleep disturbances, gastrointestinal discomfort, headache, or dizziness. Rarely, allergic reactions or worsening of symptoms in patients with severe kidney disease can occur.

Used for the management of cognitive impairment, memory disorders, post-stroke rehabilitation, age-related mental decline, and certain neurological conditions like vertigo and dyslexia. It may also be used to improve brain function in elderly patients.

Should be administered only under the supervision of a healthcare professional. Caution is advised in patients with kidney disorders, bleeding disorders, or a history of brain hemorrhage. Not recommended during pregnancy or breastfeeding unless prescribed by a doctor.

Store below 25°C. Protect from light and do not freeze. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Xurocitam-60 Injection (Piracetam 200mg/ml Injection) in the PCD pharma franchise market?

Xurocitam-60 Injection (Piracetam 200mg/ml Injection) has consistent demand in the neurology, critical care, rehabilitation, and hospital care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty neurology and hospital injectable portfolios.

Why should medical distributors include Xurocitam-60 Injection (Piracetam 200mg/ml Injection) in their product range?

Medical distributors and agencies can benefit from consistent demand for neurological care under specialist medical supervision. Piracetam 200mg/ml is a nootropic agent that helps improve neuronal function and supports cerebral metabolism and microcirculation without causing significant vasodilation Commonly prescribed for the treatment of cortical myoclonus, where it is used to help reduce the frequency and severity of involuntary muscle jerks, as advised by neurologists In some clinical settings, Piracetam may also be used for other neurological conditions based on local prescribing practices and specialist clinical judgment. Such uses may vary by country and approved product labeling Administered by intravenous infusion or injection under medical supervision, with dosage individualized according to the patient's age, renal function, and clinical condition Requires appropriate monitoring, particularly in patients with renal impairment, as dosage adjustment may be necessary. Treatment should be supervised by a qualified healthcare professional Frequently utilized in neurology departments, intensive care units (ICUs), rehabilitation centers, and tertiary care hospitals Widely prescribed by neurologists, intensivists, and rehabilitation specialists for appropriate clinical indications This strengthens a comprehensive neurology and hospital injectable portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Xurocitam-60 Injection (Piracetam 200mg/ml Injection)?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Xurocitam-60 Injection (Piracetam 200mg/ml Injection) with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent hospital and institutional demand, strong neurology market opportunities, reliable supply chain support, repeat procurement, and attractive margins in the specialty injectable segment.

How can I become a distributor or franchise partner for Xurocitam-60 Injection (Piracetam 200mg/ml Injection)?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality neurology and hospital injectable products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.